Summary

The global Artificial Vascular Grafts market is projected to grow from US$ 3859 million in 2024 to US$ 4926 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Artificial Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Artificial Vascular Grafts market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Getinge
Bard PV
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Maquet
AORTEC
CryoLife
LifeNet Health
Segment by Type
ePTFE Vascular Graft
Polyester Vascular Graft
PTFE Vascular Graft
Others
Segment by Application
Cardiovascular Diseases
Aneurysm
Vascular Occlusion
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Artificial Vascular Grafts study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Artificial Vascular Grafts: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Artificial Vascular Grafts Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ePTFE Vascular Graft
1.2.3 Polyester Vascular Graft
1.2.4 PTFE Vascular Graft
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Artificial Vascular Grafts Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Diseases
1.3.3 Aneurysm
1.3.4 Vascular Occlusion
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Vascular Grafts Revenue Estimates and Forecasts 2020-2031
2.2 Global Artificial Vascular Grafts Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Artificial Vascular Grafts Sales Estimates and Forecasts 2020-2031
2.4 Global Artificial Vascular Grafts Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Artificial Vascular Grafts Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Artificial Vascular Grafts Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 ePTFE Vascular Graft Market Size by Manufacturers
3.5.2 Polyester Vascular Graft Market Size by Manufacturers
3.5.3 PTFE Vascular Graft Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Artificial Vascular Grafts Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Artificial Vascular Grafts Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Artificial Vascular Grafts Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Artificial Vascular Grafts Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Artificial Vascular Grafts Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Artificial Vascular Grafts Sales and Revenue by Type (2020-2031)
6.4 North America Artificial Vascular Grafts Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Artificial Vascular Grafts Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Artificial Vascular Grafts Sales and Revenue by Type (2020-2031)
7.4 Europe Artificial Vascular Grafts Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Artificial Vascular Grafts Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Artificial Vascular Grafts Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Artificial Vascular Grafts Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Artificial Vascular Grafts Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Artificial Vascular Grafts Sales and Revenue by Type (2020-2031)
9.4 Central and South America Artificial Vascular Grafts Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Artificial Vascular Grafts Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Artificial Vascular Grafts Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Artificial Vascular Grafts Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Artificial Vascular Grafts Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Getinge
11.1.1 Getinge Corporation Information
11.1.2 Getinge Business Overview
11.1.3 Getinge Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.1.4 Getinge Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Getinge Artificial Vascular Grafts Sales by Product in 2024
11.1.6 Getinge Artificial Vascular Grafts Sales by Application in 2024
11.1.7 Getinge Artificial Vascular Grafts Sales by Geographic Area in 2024
11.1.8 Getinge Artificial Vascular Grafts SWOT Analysis
11.1.9 Getinge Recent Developments
11.2 Bard PV
11.2.1 Bard PV Corporation Information
11.2.2 Bard PV Business Overview
11.2.3 Bard PV Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.2.4 Bard PV Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bard PV Artificial Vascular Grafts Sales by Product in 2024
11.2.6 Bard PV Artificial Vascular Grafts Sales by Application in 2024
11.2.7 Bard PV Artificial Vascular Grafts Sales by Geographic Area in 2024
11.2.8 Bard PV Artificial Vascular Grafts SWOT Analysis
11.2.9 Bard PV Recent Developments
11.3 Terumo
11.3.1 Terumo Corporation Information
11.3.2 Terumo Business Overview
11.3.3 Terumo Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.3.4 Terumo Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Terumo Artificial Vascular Grafts Sales by Product in 2024
11.3.6 Terumo Artificial Vascular Grafts Sales by Application in 2024
11.3.7 Terumo Artificial Vascular Grafts Sales by Geographic Area in 2024
11.3.8 Terumo Artificial Vascular Grafts SWOT Analysis
11.3.9 Terumo Recent Developments
11.4 W. L. Gore
11.4.1 W. L. Gore Corporation Information
11.4.2 W. L. Gore Business Overview
11.4.3 W. L. Gore Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.4.4 W. L. Gore Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 W. L. Gore Artificial Vascular Grafts Sales by Product in 2024
11.4.6 W. L. Gore Artificial Vascular Grafts Sales by Application in 2024
11.4.7 W. L. Gore Artificial Vascular Grafts Sales by Geographic Area in 2024
11.4.8 W. L. Gore Artificial Vascular Grafts SWOT Analysis
11.4.9 W. L. Gore Recent Developments
11.5 Japan Lifeline
11.5.1 Japan Lifeline Corporation Information
11.5.2 Japan Lifeline Business Overview
11.5.3 Japan Lifeline Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.5.4 Japan Lifeline Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Japan Lifeline Artificial Vascular Grafts Sales by Product in 2024
11.5.6 Japan Lifeline Artificial Vascular Grafts Sales by Application in 2024
11.5.7 Japan Lifeline Artificial Vascular Grafts Sales by Geographic Area in 2024
11.5.8 Japan Lifeline Artificial Vascular Grafts SWOT Analysis
11.5.9 Japan Lifeline Recent Developments
11.6 B.Braun
11.6.1 B.Braun Corporation Information
11.6.2 B.Braun Business Overview
11.6.3 B.Braun Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.6.4 B.Braun Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 B.Braun Recent Developments
11.7 LeMaitre Vascular
11.7.1 LeMaitre Vascular Corporation Information
11.7.2 LeMaitre Vascular Business Overview
11.7.3 LeMaitre Vascular Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.7.4 LeMaitre Vascular Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 LeMaitre Vascular Recent Developments
11.8 Suokang
11.8.1 Suokang Corporation Information
11.8.2 Suokang Business Overview
11.8.3 Suokang Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.8.4 Suokang Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Suokang Recent Developments
11.9 Chest Medical
11.9.1 Chest Medical Corporation Information
11.9.2 Chest Medical Business Overview
11.9.3 Chest Medical Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.9.4 Chest Medical Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Chest Medical Recent Developments
11.10 Maquet
11.10.1 Maquet Corporation Information
11.10.2 Maquet Business Overview
11.10.3 Maquet Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.10.4 Maquet Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Maquet Recent Developments
11.11 AORTEC
11.11.1 AORTEC Corporation Information
11.11.2 AORTEC Business Overview
11.11.3 AORTEC Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.11.4 AORTEC Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 AORTEC Recent Developments
11.12 CryoLife
11.12.1 CryoLife Corporation Information
11.12.2 CryoLife Business Overview
11.12.3 CryoLife Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.12.4 CryoLife Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 CryoLife Recent Developments
11.13 LifeNet Health
11.13.1 LifeNet Health Corporation Information
11.13.2 LifeNet Health Business Overview
11.13.3 LifeNet Health Artificial Vascular Grafts Product Models, Descriptions and Specifications
11.13.4 LifeNet Health Artificial Vascular Grafts Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 LifeNet Health Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Artificial Vascular Grafts Industry Chain
12.2 Artificial Vascular Grafts Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Artificial Vascular Grafts Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Artificial Vascular Grafts Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Artificial Vascular Grafts Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Artificial Vascular Grafts Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details